近岸蛋白 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	128.0M	153.0M	265.0M	342.0M	180.0M
Revenue Growth %	-16.3%	-42.3%	-22.5%	90.0%	--
Total Revenue	128.0M	153.0M	265.0M	342.0M	180.0M
Cost Of Revenue	48.0M	37.3M	36.2M	42.1M	19.3M
+Gross Profit	80.0M	115.7M	228.8M	299.9M	160.7M
Gross Margin %	62.5%	75.6%	86.3%	87.7%	89.3%
Total Operating Cost	201.0M	176.0M	176.0M	167.0M	87.0M
Selling Expenses	51.9M	43.6M	35.1M	27.1M	21.7M
Admin Expenses	49.2M	44.3M	47.8M	42.2M	18.2M
Rd Expenses	49.9M	44.8M	41.1M	34.1M	15.0M
Finance Expenses	-34.0M	-27.5M	-7.2M	1.3M	3.2M
+Operating Income	-53.1M	6.5M	105.0M	177.0M	94.2M
Operating Margin %	-41.5%	4.3%	39.6%	51.8%	52.3%
Non Operating Income	48,300	21.00	2.6M	25,400	400.00
Non Operating Expenses	1.2M	289,800	1.3M	763,900	42,700
Investment Income	4.6M	18.9M	604,700	995,000	111,200
Fair Value Change Income	-1.8M	-1.7M	3.6M	-143,600	143,600
Asset Disposal Income	141,600	100.00	42,500	32,000	--
Asset Impairment Loss	32.1M	33.4M	18.1M	12.5M	5.7M
Other Income	17.5M	11.7M	11.7M	1.3M	1.1M
Income Before Tax	-54.2M	6.2M	106.0M	176.0M	94.1M
Income Tax	198,000	-6.6M	15.5M	27.2M	11.1M
+Net Income	-54.4M	12.8M	90.7M	149.0M	83.0M
Net Margin %	-42.5%	8.4%	34.2%	43.6%	46.1%
Net Income Attributable	-54.4M	12.8M	90.7M	149.0M	83.0M
Eps Basic	-0.78	0.18	1.59	3.73	--
Eps Diluted	-0.78	0.18	1.59	3.73	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	647.0M	864.0M	930.0M	189.0M	68.6M
Trading Financial Assets	--	622.0M	967.0M	--	25.1M
Accounts Receivable	60.0M	67.0M	119.0M	96.6M	23.0M
Notes Receivable	--	400,000	--	--	--
Notes And Accounts Receivable	60.0M	67.4M	119.0M	96.6M	23.0M
Prepayments	2.1M	5.2M	2.9M	3.6M	487,600
Inventory	76.1M	85.0M	77.1M	37.2M	18.7M
Total Current Assets	2.0B	2.1B	2.1B	332.0M	145.0M
Fixed Assets	--	37.2M	41.8M	32.0M	12.8M
Fixed Assets Total	40.9M	37.2M	41.8M	32.0M	12.8M
Construction In Progress	--	24.4M	16.9M	16.2M	--
Construction In Progress Total	74.9M	31.3M	17.7M	21.2M	--
Intangible Assets	18.2M	18.7M	18.2M	6.7M	105,800
Long Term Deferred Expenses	10.8M	9.7M	5.6M	4.9M	2.6M
Total Non Current Assets	262.0M	229.0M	198.0M	181.0M	26.5M
Total Assets	2.2B	2.3B	2.3B	513.0M	172.0M
Short Term Borrowings	--	--	--	--	--
Accounts Payable	28.3M	17.9M	20.9M	23.6M	8.2M
Advance Receipts	--	--	--	--	--
Contract Liabilities	5.0M	4.2M	4.8M	11.6M	13.2M
Total Current Liabilities	67.2M	50.1M	64.0M	71.8M	67.3M
Total Non Current Liabilities	49.3M	60.3M	69.2M	81.6M	1.5M
Total Liabilities	116.0M	110.0M	133.0M	153.0M	68.8M
Paid In Capital	70.2M	70.2M	70.2M	52.6M	15.9M
Capital Reserve	2.0B	1.9B	1.9B	208.0M	31.5M
Surplus Reserve	18.3M	18.3M	16.8M	12.0M	9.3M
Retained Earnings	60.0M	150.0M	173.0M	86.8M	46.3M
Equity Attributable	2.1B	2.2B	2.2B	360.0M	103.0M
Total Equity	2.1B	2.2B	2.2B	360.0M	103.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	159.0M	228.0M	248.0M	304.0M	188.0M
Tax Refunds Received	674,100	11.9M	10.0M	4.7M	2.5M
Total Operating Cash Inflow	193.0M	280.0M	281.0M	312.0M	197.0M
Cash Paid For Goods	24.3M	42.2M	57.4M	51.2M	20.9M
Cash Paid To Employees	108.0M	120.0M	112.0M	71.4M	38.6M
Taxes Paid	15.9M	14.6M	68.7M	75.9M	24.3M
Total Operating Cash Outflow	179.0M	211.0M	278.0M	241.0M	99.7M
Operating Cash Flow	13.3M	69.2M	3.4M	71.0M	97.6M
Total Investing Cash Inflow	2.1B	3.9B	233.0M	178.0M	21.1M
Total Investing Cash Outflow	2.3B	4.0B	1.2B	222.0M	57.8M
Investing Cash Flow	-158.0M	-81.4M	-999.0M	-44.0M	-36.7M
Cash From Borrowings	--	--	--	--	13.0M
Dividends And Interest Paid	35.1M	35.1M	--	16.3M	1.0M
Debt Repayments	--	--	--	--	17.0M
Total Financing Cash Inflow	422,100	--	1.7B	118.0M	33.0M
Total Financing Cash Outflow	73.0M	53.9M	11.3M	23.1M	27.6M
Financing Cash Flow	-72.6M	-53.9M	1.7B	94.5M	5.4M
Net Change In Cash	-217.0M	-65.6M	740.0M	121.0M	64.4M
Ending Cash Balance	647.0M	864.0M	929.0M	189.0M	68.6M
Capex	44.9M	44.9M	36.8M	70.0M	11.8M